drugset / Trial / NCT01613261
Study of TAK-733 in Combination With Alisertib in Adult Patients With Advanced Nonhematologic Malignancies
NaSingle-groupOpen-labelTreatment
Summary
This is a Multicenter, Open-label, Phase 1b Study of TAK-733 in Combination With Alisertib in Adult Patients With Advanced Nonhematologic Malignancies
Timeline
- Start
- 2013-08
- Primary completion
- 2015-09
- Completion
- 2015-11
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Alisertib | Small molecule | — | Oral |
| Subject | TAK-733 | Small molecule | — | Oral |